The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy

By Ozerdem Ugur   Mach-Hofacre Beata   Cheng Lingyun   Chaidhawangul Sunan   Keefe Kelly   McDermott Charles D.   Bergeron-Lynn Germaine   Appelt Krzysztof   Freeman William R.  

Current Eye Research, Vol. 20, Iss. 6, 2000-06 ,pp. : 447-453

Informa Healthcare

Access to resources Recommend Favorite

The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on uveal melanoma rabbit model

By Ozerdem Ugur   Mach-Hofacre Beata   Varki Nissi   Folberg Robert   Mueller Arthur J.   Ochabski Renata   Pham Tony   Appelt Krzysztof   Freeman William R.  

Current Eye Research, Vol. 24, Iss. 2, 2002-02 ,pp. : 86-91

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Prinomastat® (AG3340), a matrix metalloprotease inhibitor, in treatment of retinal neovascularization

By Garcia Claudio R.   Bartsch Dirk-Uwe   Rivero Maria E.   Hagedorn Martin   McDermott Charles D.   Bergeron-Lynn Germaine   Cheng Lingyun   Appelt Krzysztof   Freeman William R.  

Current Eye Research, Vol. 24, Iss. 1, 2002-01 ,pp. : 33-38

Informa Healthcare

Access to resources Recommend Favorite

Proteomics of Post-Traumatic Proliferative Vitreoretinopathy in Rabbit Retina Reveals Alterations to a Variety of Functional Proteins

By Zhou Qingyun   Xu Guangjun   Zhang Xuedong   Cao Chen   Zhou Zhongqiang  

Current Eye Research, Vol. 37, Iss. 4, 2012-04 ,pp. : 318-326

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Experimental Proliferative Vitreoretinopathy with Protein Kinase C Inhibitor (Chelerythrine Chloride) and Melatonin

By  

Ophthalmologica, Vol. 220, Iss. 1, 2005-12 ,pp. : 17-22

Karger

Access to resources Recommend Favorite